The Patent Finder

Abbott Diagnostics Scarborough, Inc.

25 patents currently held · Updated Nov 17, 2026
1 more in force is now held by another company
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
7
Ending by 2030
May 2027
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Apr 13, 2027
    The maintenance fee for Monitoring Recombinase Polymerase Amplification Mixtures (US 9,157,127) comes due Apr 13, 2027. Unpaid by Oct 13, 2027, it lapses early.
  • 1 fee due Jul 16, 2027
    The maintenance fee for Microfluidic Devices and Related Methods (US 11,872,554) comes due Jul 16, 2027. Unpaid by Jan 18, 2028, it lapses early.
  • 1 fee due Oct 28, 2027
    The maintenance fee for Microfluidic Devices and Related Methods (US 10,632,464) comes due Oct 28, 2027. Unpaid by Apr 28, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 1 of the patents on this record was granted since Aug 19, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 8,637,253Recombinase Polymerase Amplification
In force
 · High confidence
In forceHigh confidence
US 10,093,908Recombinase Polymerase Amplification
In force
 · High confidence
In forceHigh confidence
US 12,227,773Recombinase Polymerase Amplification
In force
 · Medium confidence
In forceMedium confidence
US 7,879,612Organic Non-Sugar Compounds for Protection of Biologically Active Molecules and Conjugate Labels and Methods of Use Thereof
In force
 · Medium confidence
In forceMedium confidence
US 8,071,308Recombinase Polymerase Amplification
In force
 · High confidence
In forceHigh confidence
US 9,469,867DNA Glycosylase/Lyase and AP Endonuclease substrates
In force
 · High confidence
In forceHigh confidence
US 9,896,719DNA Glycosylase/Lyase and AP Endonuclease Substrates
In force
 · High confidence
In forceHigh confidence
US 8,951,532A25 Bacteriophage Lysin
In force
 · High confidence
In forceHigh confidence
US 9,562,901A25 bacteriophage lysin
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,040,061System and apparatus for reactions
In force
 · From the USPTO record
In forceFrom the USPTO record
10 of 25 patents shown.
Pro members see all 25.
Pro members: see all 25 patents
Also on record, not counted in the 25: 1 patent in force now held by others · 35 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

7 pending · 2 abandoned · 1 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited